News MHRA lays out its thinking on AI and medicines regulation An MHRA document explaining how regulations will adapt to the era of AI and personalised medicine has been well received by the pharma industry.
News European biotech leaders say optimism is returning Senior figures in European biopharma think dealmaking and M&A will increase in the region, and could be helped by US policy uncertainties.
News UK watchdog takes first action on oral weight drug adverts Online pharmacies operating in the UK breached Advertising Standards Authority rules by promoting oral weight drugs to the public.
News UK backs all health AI proposals in commission report The UK will accept all 44 proposals made in a recent report on using AI tools in the NHS, including continuous monitoring after deployment.
News Novo faces delay in US review of haemophilia drug The FDA has extended its review of Novo's experimental haemophilia A drug denecimig because of ongoing remediation work at a manufacturing facility.
News Two men charged with infiltrating fake Ozempic into US Two Indian nationals are facing charges relating to the sale of counterfeit versions of Novo's diabetes treatment Ozempic to distributors in the US.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.